-
1 .
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- 저자
- by Obbina Abani; Ali Abbas; Fatima Abbas; Mustafa Abbas; Sadia Abbasi, et al.
- 소스
- RECOVERY Collaborative Group & Downey, D 2021, ' Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10285, pp. 1637-1645 . https://doi.org/10.1016/S0140-6736(21)00676-0
Mumford, A D 2021, ' Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10285, pp. 1637-1645 . https://doi.org/10.1016/S0140-6736(21)00676-0
RECOVERY Collaborative Group, Felton, T, Murray, C, Evans, D G, Dark, P & Buch, M 2021, ' Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10285, pp. 1637-1645 . https://doi.org/10.1016/S0140-6736(21)00676-0
Lancet (London, England)